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Background: Creep feeding is used to stimulate piglet post-weaning feed consumption. L-Glutamine (GLN) is an
important source of fuel for intestinal epithelial cells. The objective of this study was to determine the impact of
creep feeding and adding GLN or AminoGut (AG; containing glutamine + glutamate) to pre- and post-weaning
diets on pig performance and intestinal health. Litters (N = 120) were allotted to four treatments during 14–21 d of
lactation: 1) No creep feed (NC, n = 45); 2) creep fed control diet (CFCD, n = 45); 3) creep fed 1% GLN (CFGLN,
n = 15); 4) creep fed .88% AG (CFAG, n = 15). After weaning, the NC and CFCD groups were sub-divided into three
groups (n = 15 each), receiving either a control nursery diet (NC-CD, CFCD-CD) or a diet supplemented with either
GLN (NC-GLN, CFCD-GLN) or with AG (NC-AG, CFCD-AG). Litters that were creep fed with diets containing GLN or
AG also were supplemented with those amino acids in the nursery diets (CFGLN-GLN, CFAG-AG). Glutamine was
added at 1% in all three post-weaning diet phases and AG was added at .88% in phase 1 and 2 and at .66% in
phase 3.
Results: Feed conversion (feed/gain) showed means among treatment means close to significance (P = 0.056) and
Tukey’s test for pairwise mean comparisons showed that Pigs in the CFGLN-GLN group had the best feed
conversion (feed/gain) in the first three-week period post-weaning, exceeding (P = 0.044) controls (CFCD-CD) by
34%. The NC-AG group had (P = 0.02) the greatest feed intake in the last three week of the study, exceeding
controls (CFCD-CD) by 12%. CFGLN-GLN, CFCD-GLN and sow reared (SR) pigs had the greatest (P = 0.049) villi
height exceeding the CFCD-AG group by 18%, 20% and 19% respectively. The CFAG-AG group had the deepest
(P = 0.001) crypts among all treatments. CFGLN-GLN, CFCD-GLN and SR groups had the greatest (P = 0.001) number
of cells proliferating (PCNA) exceeding those in the NC-CD group by 43%, 54% and 63% respectively. Sow reared
pigs showed the greatest (P = 0.001) intestinal absorption capacity for xylose and mannitol.
Conclusion: Supplementation of creep feed and nursery diets with GLN and/or AminoGut in the first three week
improved feed conversion possibly due to improved intestinal health.
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After pigs are weaned from their dams, morphological and
functional changes occur in their small intestine. Pluske
et al. [1] reported decreased villi height and increased
crypt dept. Because newly-weaned pigs are transitioned
from milk to dry feed, the pig’s intestinal tract is unable to
fully digest and absorb the more complex plant-based
macronutrients in the feed. Various researchers [2,3] have
reported that this accumulation of undigested and un-
absorbed feed creates the perfect medium for opportunis-
tic bacteria such as haemolytic E. coli to grow. The normal
weaning process stimulates pancreatic development and
its enzymatic output; however there is a delay until the
different enzymes reach sufficient levels [4]. This in turn
can cause post-weaning diarrhea. Creep feeding is deemed
to be very important during the suckling period for swine
practitioners because it (a) increases weaning weight when
offered in small and frequent quantities and (b) eases the
transition period for the piglets from sow’s milk to the dry
feed. The latter has a physiological implication in order to
avoid digestive upset such as post-weaning diarrhea and
poor growth. Some argue [5,6] that the use of creep feed
during the suckling period could potentially trigger hyper-
sensitivity to feed antigens that can stimulate post-
weaning diarrhea. Barnett et al. [7] observed antibody
titers in the blood of weaned piglets and confirmed that
feed antigens can induce an immune reaction in creep-fed
pigs. The reduction in feed intake associated with weaning
has been known to affect intestinal integrity and poten-
tially cause pathological disorders. Klasing [8] argued that
dietary supplementation of some nutrients or immune
modulators can rectify the intestinal impairment and
modulate the immune function of animals contributing
to improvements in overall health and performance.
Nutrition can regulate the type of immune response by
a number of mechanisms [8]. Swine nutritionists have
traditionally focused on those amino acids that cannot
be synthesized by the animals with little attention given
to those that can be synthesize by the animals and yet
have a great impact on regulating nutrient metabolism
and the immune responses [9,10]. These amino acids
include arginine, glutamine, glutamate, proline, leucine,
cysteine and tryptophan. Recent studies indicate that
these amino acids serve important regulatory functions
in nutrient metabolism, protein turnover, and immune
function, thereby enhancing growth and feed efficiency
in pigs. The underlying mechanisms include activation of
nitric oxide, mammalian target of rapamycin (mTOR),
gaseous signaling, and AMP-activated protein kinase path-
ways as well as anti-oxidative [11].
Glutamine is a major metabolic fuel for rapidly divid-
ing cells, including enterocytes and lymphocytes, as well
as a key regulator of gene expression and cell signaling
pathways [12]. Schrock and Goldstein [13] reported thatglutamine serves as precursor for the increased renal
ammoniagenesis during chronic metabolic acidosis. The
amide nitrogen of glutamine is essential for purine and
pyrimidine biosynthesis.
Glutamine has important and unique metabolic func-
tions, and it is considered a conditionally essential amino
acid in some species under inflammatory conditions [14]
and disease states [15,16]. Souba and others [17] have
indicated that the provision of GLN-enriched diets in
various stress states associated with bacterial transloca-
tion decreases the incidence of translocation of bacteria
by decreasing the adherence of bacteria to enterocytes.
Reeds and others [18] argued that the high metabolic
rate of the intestinal mucosa is very unique when com-
pared to the others organs in the body. First, the
enterocytes are specialized in absorbing nutrients from
the lumen to the basal lamina. Second, mucosa cells are
presented with high quantities of substrates from both
the intestinal lumen and the mesenteric arterial circula-
tion. Accordingly, under fed conditions, the quantifica-
tion of substrate used by the gut can be challenging to
quantify given the dual supply from both diet and the
arterial circulation. Finally, GLN is the only amino acid
in arterial blood that is taken up by the small intestine
in swine [19]. The small intestine (even though only
represents 3 to 4% of the body weight) utilizes 30% of
the arterial GLN and 67% of dietary GLN in swine. For
comparison, 95 to 97% of dietary glutamate is extracted
by the pig small intestine in first pass [20,21] but only
50% is metabolized to CO2 [18].
Because the gastrointestinal tract has an obligatory
requirement for L-GLN [18] and availability of L-GLN
from endogenous tissue production may not be sufficient
for the maintenance of the structural and functional integ-
rity of the intestinal mucosa [22,23], We hypothesized that
creep feeding of suckling piglets and adding L-glutamine
or the combination of L-glutamine and L-glutamate to pre
and/or post-weaning diets would alleviate villi atrophy, re-
duce post-weaning diarrhea and improve post-weaning
growth.
The objective of the study was to evaluate the effects
of L-GLN and AminoGut (containing L-GLN and L-
glutamate) on intestinal histology, intestinal absorptive
capacity, enzymatic activity, and growth performance in
a commercial swine operation. The effects of these sup-
plements on piglet growth performance have not been
evaluated during the whole nursery period following
supplementation during the pre-weaning period.
Methods
All protocols were under the supervision of licensed vet-
erinarians. Standard operating procedures for animal
care were in accord with published guidelines for animal
care [24]. The experimental animals were not subjected
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humanely treated throughout the experiment. The study
was conducted during the summer 2010 on a 4800-sow
farm in Maple Hill, NC (Murphy-Brown, LLC; Rose Hill,
NC). One-hundred and twenty litters were randomly allot-
ted to one of eight dietary treatment scenarios (Figure 1).
At one week prior to weaning, four creep-feed treatments
were initiated: A) No creep feed; B) Creep feed, control
diet; C) Creep feed containing 1% GLN; D) Creep feed
containing 0.88% AminoGut. AminoGut is a commercial
dietary supplement produced by Ajinomoto do Brazil (São
Paulo, Brazil) containing a mixture of L-glutamine (min
10%) and L-glutamate (min 10%). The pelleted creep feed
was a phase 1 nursery diet (Table 1), manufactured at the
North Carolina State University feed mill. Litters were of-
fered fresh creep feed at 4-h intervals from 8 am to 4 pm
each day. Litters weights were recorded at birth (WayPig
model 252, Raytec Manufacturing, Ephrata, PA) and
weaning (Avery Weight-Tronix model 640, www.agscales.
com, Fairmont, MN). Pigs were weaned at an average of
21 d and were transported to the Site 2 nursery (~ 300
meters from farrowing Site 1), and litters from pre-
weaning treatments A and B were each divided among the
following nursery diets: 1) Control diet, 2) GLN diet, and
3) AminoGut diet (Figure 1, Table 1). Litters from pre-
weaning treatments C and D were continued on similar
diets post-weaning (e.g., GLN and AminoGut respect-
ively). Additional litters were allowed to nurse the sow
(without creep feed) until 4 week of age to provide age-
matched controls for invasive measures of intestinal health
(n = 7). The experimental design is illustrated in Figure 1,Figure 1 Experimental design showing four pre-weaning creep diet g
reared control pigs. Creep feed was initiated 1 week prior to weaning an
either control basal diet (see Table 1) with additions of either 1% L-GLN (in
in Phase 3. Pigs were weighted at birth, weaning, (some at 1 wk post-wean
(n = 7/trt) at 1 wk post-weaning for intestinal health measurements. Varioushowing abbreviations used for each dietary treatment sce-
nario. After weaning, phase 1 diet (Table 1) was budgeted
at 2.72 kg /pig, Phase 2 diet was budgeted at 5.45 kg/pig
and Phase 3 diets was budgeted at 18.16 kg /pig. At 3 and
6 week postweaning, the pigs and feeders were weighed
for growth and feed conversion calculations.
At one week post weaning, one pig per pen was fasted
overnight and then intra-gastrically gavaged with a D-
xylose/mannitol solution as follows. A solution containing
0.2 g/L of D-xylose (Pfizer, N.Y., NY) and 0.3 g/L of man-
nitol (Sigma, Saint Louis, MO) was prepared and was
given to the pigs on an average of 9.5 h after fasting.
The selected dose was 6.5 mL/kg of body weight. Pigs
were individually weighed (Berkley FS-50 hanging scale,
Somers Point, NJ). At precisely two h post gavage, pigs
were bled via jugular venipuncture. The time of bleed-
ing was selected based upon work by Doerfler et al.
[25]. After pigs were bled they were humanly eutha-
nized for collection of intestinal tissues. Jejunum sam-
ples (25 cm from the stomach) were collected for both
light and scanning electron microscopy (SEM). The
portion cut specifically for SEM, was cut open and laid
flat in a small cartridge in order to obtain a better pic-
ture of the intestinal villi. A separate jejunum tissue
sample was cut and the intestinal mucosa was scrapped
for maltase activity analysis. Blood was centrifuged after
24 h and the serum stored at −20°C for further analysis.
Performance data were statistically analyzed using the
PROC GLIMMIX of SAS with birth weight and weaning
age as covariates. Intestinal and serum metabolite data
were analyzed using the Mixed Procedure of SAS withroups and eight post-weaning diet groups together with sow-
d consisted of pelleted Phase 1 diets. Post-weaning diets consisted of
all feed Phases 1–3) or 0.88% AminoGut in Phases 1 and 2 and 0.66%
ing), 3 wk and 6 wk post-weaning. Selected pigs were euthanized
s treatment abbreviations are also summarized.
Table 1 Ingredients and nutrient composition of the
basal diets (Phase 1, 2 and 3)1
Ingredients, % Phase 1 Phase 2 Phase 3
Corn 39.00 51.36 63.73
Soybean meal, 48% 20.00 25.00 30.00
Choice white grease 3.00 3.00 3.00
Dicalcium 0.00 0.60 1.30
Limestone 0.55 0.60 0.50
Salt 0.30 0.30 0.50
l-Lysine 0.25 0.27 0.39
DL-Methionine 0.21 0.18 0.18
L-Threonine 0.16 0.16 0.19
L-Tryptophan 0.02 0.02 0.00
Granular whey 5.00 0.00 0.00
Porcine plasma protein 4.00 2.00 0.00
Dairy Lac 80 20.00 10.00 0.00
Fish meal select 6.00 5.00 0.00
ZnO 0.30 0.30 0.00
Copper sulfate 0.05 0.05 0.05
Vitamins Mix2 0.01 0.01 0.01
Trace mineral Mix3 0.15 0.15 0.15
Mecadox 1.00 1.00 0.00
Total 100.00 100.00 100.00
Calculated nutrients
ME (Mcal/kg) 3.52 3.46 3.46
CP, % 21.67 21.77 20.12
TID Lysine, % 4 1.39 1.35 1.25
TID Met, % 0.52 0.50 0.45
TID M + C, % 0.83 0.81 0.75
TID Threonine, % 0.93 0.88 0.82
TID Tryptophan, % 0.25 0.25 0.21
TID Isoleucine, % 0.77 0.78 0.73
TID Valine, % 0.93 0.91 0.82
Glutamate, % 3.69 3.79 3.62
Total P, % 0.64 0.67 0.63
Available P, % 0.43 0.40 0.30
Ca, % 0.80 0.80 0.60
Na, % 0.32 0.21 0.21
Lactose, % 19.50 8.00 0.00
1L-Glutamine was supplemented at 1% of the diet at the expense of corn.
Amino-Gut was supplemented 0.8% in phase 1 and 2; and at 0.6% in phase 3.
2Vitamin Mix contained per kg of premix: vitamin A Acetate 4,231,292 IU;
vitamin D3 603,174 IU; vitamin E ascorbate 24,172 IU; vitamin B12 14.97 mg;
riboflavin spray dried 3,023 mg; niacin 18,140 mg; d-pantothenic 12,093 mg;
menadione 1,995 mg; folic acid spray dried 907 mg; biotin spray
dried 121 mg.
3Trace mineral Mix contained: ferrous sulfate 11.02%; copper sulfate 1.10%;
ethylenediamine dihydriodine 198 ppm; manganese oxide 2.64%; sodium
selenite 198.4 ppm; zinc sulfate 11.02%.
4Total ileal digestible lysine.
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used as covariate.Scanning electron microscopy
Jejunum samples were collected from four-week old pig-
lets (1 wk post-weaning) and immersed in 4 F:1G fixa-
tive containing 4% formaldehyde and 1% glutaraldehyde
in a phosphate buffer, with an osmolarity of 176 mOsM
and a pH of 7.2-7.4 [26]. Samples were cut to be
between 2–3 mm in order to minimize chances of bulk
charging. Samples were rinsed in 0.1 mol/L phosphate
buffer and dehydrated in an ethanolic series to 100%
ethanol before subjection to critical point drying after
being stored for approximately 7 wk in the 4 F: 1G
fixative. Samples were then mounted on SEM stubs with
carbon tape and sputter coated with gold-palladium
before being viewed with a JEOL JSM-6360LV scanning
electron microscope (JEOL, Peabody, MA). This micro-
scope is a fully digital instrument that can view speci-
mens by secondary electron imaging (SEI), backscatter
electron imaging (BEI), at high vacuum, or at low
vacuum.
Hematoxylin & eosin staining
Jejunum samples were collected (25 cm from the stomach)
and preserved in a formalin solution and stored in room
temperature for histology analysis. Tissues were trimmed
into five millimeter thick sections and placed in processing
cassettes. The tissues were processed in a Tissue-Tek VIP5
tissue processor (Sakura Finetek, Torrance, CA) using a
standard overnight processing schedule. Tissues were
embedded in paraffin and five micron sections were
mounted on glass slides. The slides were stained on a
DRS-601 slide stainer (Sakura Finetek, Torrance, CA) with
hematoxylin and eosin, cleared and mounted with a
permanent media. The stained tissues on glass slides were
examined using an Olympus AH-2 Vanox-S microscope
(Ultrasonic Power Corporation, Freeport, IL) and mea-
sured using SPOT™ software (SPOT™ Imaging Solutions,
Sterling Heights, MI).
PCNA Staining
Five micron jejunal slices were mounted on glass slides.
A primary mouse monoclonal antibody (PC10) was used
for the as a proliferation marker. This antibody is spe-
cific for proliferating cell nuclear antigen, PCNA, p36
protein expressed at high levels in proliferating cells. It
was diluted at 1:1,500 and incubated for 30 min. The
remaining steps were completed using the Dako EnVision
Mouse kit (Dako, Denmark). Intensively stained and the
total number of enterocytes were counted in 8 consecu-
tive well-orientated crypts (those that extended to the
muscularis mucosa).
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Samples of serum were frozen, thawed at room tempe-
rature and vortexed to mix. Samples were then filtered by
centrifugation using Ultrafiltration Spin Columns (0.45 μm,
Millipore, Temecula, CA). An aliquot of 200 μL of sample
was transferred to HPLC autosampler vials containing
250 μL inserts. An internal standard solution of myo-
inositol was added (2 μL). Analysis was done using High
Performance Liquid Chromatography (HPLC). The extracts
were analyzed using a Dionex BioLC (Dionex Corporation,
Sunnyvale, CA) at a controlled temperature of 30°C. The
system consisted of a gradient pump, an autosampler,
and a pulsed amperometric detector. The mobile phase
was 52 mmol/L NaOH (Thermo-Fisher Chemical Corp.
Pittsburgh, PA) at an isocratic flow rate of 1.0 mL/min. The
column used was a Dionex PA-10, 250 mm length and
4 mm i.d., fitted with Dionex PA-10 and borate guard
columns. The detector was programmed to run a quadru-
ple waveform as recommended by the manufacturer. A
shift in the detector range was 1 μC. The injection volume
was 10 μL. The mannitol was calculated using an authen-
tic standard of d-mannitol and myo-inositol as an internal
standard. All the reference standards were purchased from
Sigma Chemical Corp (St. Louis, MO).
Analysis of xylose
The collected pig serum (20 μL) was subjected to a
modified micro method [27,28] first described by Eberts
et al. [29] for determination of plasma D-xylose. To each
20 μL plasma sample, 2 mL of phloroglucinol (Sigma
Chemical Co., Saint Louis, MO 63178–9916) color reagent
was added and heated for 4 min at 100°C. The samples
were allowed to cool at room temperature in a water bath.
After cooling, the absorbance of each sample was read
on a Gilford UV–vis spectrophotometer (Thermo Fisher
Scientific, Inc.; Waltham, MA) set at 554 nm.
Maltase enzyme activity
The maltase assay was performed as described by
Dahlqvist [30]. Maltase activity (U/g of protein) was
expressed as units, with 1 unit defined as the amountTable 2 Pre-weaning performance of creep-fed piglets
Variables No-Creep Creep Creep + G
No. litters 45 45 1
Wean age, d 21.5 20.5 20
Pigs/litter 12.5 12.4 12
Sow parity 3.4 3.4 3
Birth wt, kg/pig 1.5 1.4 1
Wean wt, kg 6.5 6.4 6
Creep feed, g/pig1 - 49.4 45
Mortality, pigs/litter 1.0 1.2 1
1Creep feed was offered for one week prior to weaning.of enzyme transforming 1.0 μmol of substrate per min
at 25°C.
Results
Results for pre-weaning performance are summarized in
Table 2. We found weaning age to be significant (P =
0.001) among the pre-wean treatments. For subsequent
comparisons, this variable was used as covariate. Pigs/
litter, sow parity, birth weight, weaning weight, and
mortality were not different among the treatments.
Creep feed consumption also did not differ for those treat-
ments receiving creep feed. The average creep feed con-
sumptions for the control diet and those supplemented
with either glutamine or AminoGut were 49.44, 45.57 and
48.44 g/pig respectively. We did not find an effect of creep
feeding on post-weaning performance (Tables 3 & 4). A
longer (> 1 wk) creep feed period needs to be examined.
Feed conversion (feed/gain) showed means among treat-
ments close to significance (P = 0.056) and Tukey’s test for
pairwise mean comparisons showed that Pigs in the
CFGLN-GLN group had the best feed conversion (feed/
gain) in the first three-week period post-weaning, exceed-
ing (P = 0.044) controls (CFCD-CD) by 34%. All others
variables were not significant during this post-weaning
period among the treatments (Table 3). The NC-AG
group had (P = 0.02) the greatest feed intake among all
treatments in the last three week of the study (Table 4),
exceeding controls (CFCD-CD) by 12%. All others vari-
ables were not significant during this post-weaning period
among the treatments. CFCD-GLN, Sow-Reared and
CFGLN-GLN groups had the greatest (P = 0.049) villi
height exceeding those which were creep fed with a
control diet and later supplemented with AminoGut
(CFCD-AG) by 20%, 19% and 18% respectively (Table 5).
The Sow-Reared group was added as a point of refer-
ence against the other treatments. All tissue samples for
all treatments were taken at 28 d of age. We also found
that pigs creep fed with a diet supplemented with
AminoGut and fed a post-weaning diet supplemented
with AminoGut (CFAG-AG) had the deepest (P = 0.001)
crypts among all the treatments. Sow-Reared, CFCD-lutamine Creep + AminoGut SEM P value
5 15 - -
.3 18.9 0.13 0.001
.5 11.9 0.23 0.286
.4 3.4 0.20 0.998
.4 1.5 0.04 0.250
.4 6.5 0.26 0.980
.6 48.4 2.93 0.617
.5 1.2 0.22 0.488
Table 3 Pig performance from week 1 to 3 post-weaning
Variables NC-CD1 NC-GLN NC-AG CFCD-CD CFCD-GLN CFCD-AG CFGLN-GLN CFAG-AG SEM P value
No. pens 6 6 6 6 6 6 6 6 - -
No. pigs 144 144 144 144 144 144 144 144 - -
Initial wt, kg 6.50 6.35 6.59 6.14 6.39 6.61 6.42 6.52 0.34 0.984
Final wt, kg 10.4 10.20 10.66 9.51 10.06 10.08 10.65 10.34 0.26 0.128
ADG, kg/pig 0.25 0.24 0.25 0.19 0.23 0.22 0.26 0.24 0.02 0.124
Intake, kg/pig 0.33 0.28 0.30 0.27 0.27 0.28 0.29 0.29 0.02 0.644
Feed/gain 1.35bc 1.17ab 1.17ab 1.48c 1.15ab 1.30b 1.11a 1.21ab 0.09 0.056
Mortality 0.38 1.43 0.94 1.28 0.80 0.63 0.82 0.73 0.37 0.562
Removed 1.23 0.90 2.00 2.49 1.28 1.03 1.81 0.59 0.70 0.584
1NC-CD No Creep Control Diet, NC-GLN No Creep Glutamine, NC-AG No Creep AminoGut, CFCD-CD Creep Fed Control Diet-Control Diet.
CFCD-GLN Creep Fed Control Diet-Glutamine, CFCD-AG Creep Fed Control Diet-AminoGut, CFGLN-GLN Creep Fed Glutamine-Glutamine.
CFAG-AG Creep Fed AminoGut-AminoGut. See Figure 1.
abcLeast square means within a row lacking a common superscript are different (P < 0.05).
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(P = 0.001) number of cells proliferating (PCNA), exceed-
ing those which did not receive creep feed and later re-
ceiving a control diet (NC-CD) by 63%, 54% and 43%
respectively. We found a correlation between villi height
and PNCA: the taller the villi height, the greater the num-
ber of proliferating cells. Sow-Reared pigs showed the
greatest (P = 0.001) intestinal absorption capacity for xy-
lose and mannitol when compared with the others treat-
ments. The levels of xylose and mannitol found in the sow
reared pigs blood exceeded the average of the levels found
in the other treatments by 3.2 and 7.4 folds respectively.
This is consistent with the architecture of the villi of the
sow reared pigs when compared to the other treatments
(see qualitative SEM images, Figure 2). There was no sig-
nificance difference among the other treatments on the
absorption of these sugars. We found the levels of xylose
in the blood to be higher than those of mannitol even
though a higher amount of mannitol was diluted in the
final solution (0.2 g/L vs. 0.3 g/L). We found no significant
differences among the treatments in maltase activityTable 4 Pig performance from week 3 to 6 post-weaning
Variables NC-CD1 NC-GLN NC-AG CFCD-CD CFCD
No. pens 6 6 6 6 6
Initial wt, kg 10.45 10.32 10.72 9.44 10.
Final wt, kg 22.32 21.97 22.74 22.21 22.
ADG, kg/pig 0.52 0.51 0.55 0.50 0.5
Intake, kg/pig2 0.77b 0.74b 0.86a 0.77b 0.7
Feed/gain2 1.39 1.48 1.65 1.49 1.6
Mortality,% 0.01 0.00 0.35 0.13 0.1
Removed,% 1.01 1.5 1.69 1.62 0.9
1NC-CD No Creep Control Diet, NC-GLN No Creep Glutamine, NC-AG No Creep Amin
Control Diet-Glutamine, CFCD-AG Creep Fed Control Diet-AminoGut, CFGLN-GLN Cre
Figure 1.
2For the calculation of feed intake and feed/gain, the number of pens was reduced
abcLeast square means within a row lacking a common superscript are different (P <although there was a tendency (P = 0.18) for creep fed
treatments to be numerically different than those which
did not receive creep feed (260 vs. 214 μmoles / min. g of
protein respectively).
Discussion
Windmueller and Spaeth [31] determined that in the adult
rat small intestine, CO2, lactate, alanine and glucose ac-
count for 56–64, 16–20, 4–8, and 2-10% of the total catab-
olized carbons of luminal glutamine, glutamate and
aspartate, respectively. These results and others showed
that amino acids (glutamine, glutamate and aspartate), ra-
ther than glucose, are the major fuels for the small intes-
tine mucosa, responsible for providing energy required for
intestinal ATP-dependent metabolic processes [32]. Al-
though there seems little doubt that glutamine plays an
important, but remarkably poorly characterized role in the
metabolism of many proliferating cells, much of the more
recent literature on intestinal metabolism has ignored two
observations made by Windmueller and Spaeth [33].
Those are, first, that the metabolism of luminal glutamate-GLN CFCD-AG CFGLN-GLN CFAG-AG SEM P value
6 6 6 - -
18 10.10 10.78 10.43 0.43 0.457
86 22.50 21.71 22.76 0.41 0.437
4 0.53 0.50 0.54 0.02 0.444
9b 0.79b 0.70c 0.80b 0.03 0.022
4 1.84 1.66 1.50 0.12 0.271
6 0.01 0.19 0.01 0.13 0.434
9 1.15 1.69 1.17 0.32 0.497
oGut, CFCD-CD Creep Fed Control Diet-Control Diet, CFCD-GLN Creep Fed
ep Fed Glutamine-Glutamine, CFAG-AG Creep Fed AminoGut-AminoGut. See
from 6 to 3 pens because two pens shared a common feeder.
0.05).
Table 5 Intestinal morphology, PCNA staining, and maltase activity, and serum xylose and mannitol following oral





















No. pigs 6 6 6 6 6 6 6 6 6 - -
Age pigs, d 28 28 28 28 28 28 28 28 28 - -
Body wt, kg2 6.5 6.7 6.2 5.8 6.4 6.4 6.5 6.5 6.3 0.28 0.824
Villi height, μm 508ab 515ab 510ab 560ab 576a 480b 568a 560ab 570a 23 0.049
Villi width, μm 136 140 120 133 148 158 145 147 132 8.9 0.301
Crypt depth, μm 202ab 188b 177b 192ab 218ab 242ab 225ab 258a 118c 14 0.001
PCNA, cells 56c 81a 67b 71ab 86a 70ab 80a 64b 91a 5.5 0.001
Xylose, mg/dl 14.6b 13.5b 11.1b 14.4b 9.5b 14.1b 15.4b 13.7b 42.8a 1.94 0.001
Mannitol, mg/dl 1.8b 1.5b 2.3b 1.9b 2.8b 3.0b 2.8b 3.0b 17.7a 0.68 0.001
Maltase, μmol/(min. g
protein)
256 183 201 299 282 254 244 242 239 32 0.189
1 NC-CD No Creep Control Diet, NC-GLN No Creep Glutamine, NC-AG No Creep AminoGut, CFCD-CD Creep Fed Control Diet-Control Diet.
CFCD-GLN Creep Fed Control Diet-Glutamine, CFCD-AG Creep Fed Control Diet-AminoGut, CFGLN-GLN Creep Fed Glutamine-Glutamine.
CFAG-AG Creep Fed AminoGut-AminoGut. Sow Reared were pigs kept with the sow until they were 28 d of age. See Figure 1.
2 Body weight was taken one week post-placement in the nursery. Sow reared pigs stayed with their dams for 28 d.
abc Least square means within a row lacking a common superscript are different (P < 0.05).
Cabrera et al. Journal of Animal Science and Biotechnology 2013, 4:29 Page 7 of 12
http://www.jasbsci.com/content/4/1/29was even more extensive than that of arterial glutamine;
and second, that the presence of high concentrations of
glutamate in the intestinal lumen had only a small (less
than 25%) effect on intestinal utilization of glutamine. This
perhaps suggests that these two closely related amino
acids may have different functional roles in the intestinal
mucosa.
It seems that glutamate can partially substitute for Gln
in several pathways, including ATP production and syn-
thesis of arginine, alanine, proline and aspartate [34].
Glutamate plays a significant role on avoiding Gln deg-
radation by mitochondrial phosphate-activated gluta-
minase in extra hepatic tissues and cells yielding a
sparing effect on the use of Gln as a metabolic fuel [35]
and its availability in cells [36]. Wu [10] rightly notes
that that key functions of Gln (syntheses of Gln-tRNA,
aminosugars, carbamoylphosphate, NAD, NADP, as well
as purines and pyrimidines; renal ammoniagenesis; and
regulation of ornithine decarboxylase expression) cannot
be supplied by glutamate. Wu and others [37] argued
that although both Gln and glutamate provided in the
enteral diet are extensively catabolized by the small in-
testine, this organ takes up Gln, but not glutamate, from
the arterial blood. They suggested that due to the com-
plex compartmentalization of cellular metabolism, extra-
cellular glutamate may channel preferentially into the
cytoplasm rather than into the mitochondria and, there-
fore, have different effects than the glutamate generated
from Gln in mitochondria.
The vast majority of research showing the benefits of
supplementing Gln in the diet can be found in research
with swine. Wu and co-workers [38] reported that
among all the amino acids, uterine and umbilical uptakeof Gln was the greatest in pregnant gilts, implicating an
important role for Gln in fetal growth and development.
They fed 1% Gln in the diet of gestating gilts between 90
and 114 d of gestation and found that it significantly in-
creased average birth weight. They also found that the
number of intrauterine growth retarded piglets, variation
in birth weight and pre-weaning mortality were reduced
by 39, 33, and 46%, respectively, when compared with
the control group.
Kim and Wu [39] reported that lactating sows have a
high requirement for Gln and the uptake of Gln by the
porcine mammary glands may be inadequate for the syn-
thesis of milk proteins. By d 10 during the lactating
period, the mammary glands uptake 16 g Gln/d from the
arterial circulation [40], however Haynes and others [41]
reported that at that point in time, 36 g Gln/d is being
secreted. Wu and colleagues [38] fed 1% Gln from d1 to
d 20 to lactating sows and found an increase of Gln con-
centrations in the plasma, skeletal muscle and whole
milk of the sows, as well as piglet growth and survival.
Haynes et al., [41] evaluated the effectiveness of Gln or
L-alanyl-L-glutamine (Ala-Gln) in vivo with 7-d-old
piglets challenged with a single intraperitoneal injection
LPS (0.1 mg/kg body weight). Administration of Gln or
Ala-Gln to LPS challenged piglets increased Gln concen-
trations in small intestinal lumen and plasma, reduced in-
testinal expression of TLR-4, active caspase-3 and NFkB,
ameliorated intestinal injury, decreased rectal temperature
and enhanced growth performance. These results demon-
strate a protective effect of Gln or Ala-Gln against LPS-
induced enterocytes death. They also reported that the
Gln supplementation stimulated the growth of sow-reared
piglets by 12%.
Figure 2 Scanning electron micrographs of jejunal villi of pigs at four wk of age. A. No creep Control Diet (NC-CD). B. No creep
Glutamine (NC-GLN). C. No creep AminoGut (NC-AG). D. Creep Fed Control Diet-Control Diet (CFCD-CD). E. Creep Fed Control Diet-Glutamine
(CFCD-GLN). F. Creep Fed Control-AminoGut (CFCD-AG). G. Creep Fed Glutamine-Glutamine (CFGLN-GLN). H. Creep Fed AminoGut-AminoGut
(CFAG-AG). I. Sow-Reared Control.
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cial effects in alleviating growth depression of E. coli
K88+-challenged pigs, mainly via maintaining intestinal
morphology and function, and/or possible modulating
the somatotrophic axis. Jiang and others [43] reported
similar results. Wu et al. [44] orally administered Gln
(0.5 g/kg BW/d) to low-birth weight piglets from 0 to 21
d of age and found that their growth were improved by
16% and their pre-wean mortality by 48%.Our results are most consistent with those reported by
Wu et al., [45]. They found a 29% improvement in feed
conversion (21d post-weaning) when supplementing
1% glutamine. Glutamine (Gln) supplementation (1%)
prevented jejunal atrophy (measured as villus height)
during the first week post-weaning and increased feed:
gain ratio (indicator of growth performance) by 25%
during the second week post-weaning. It also increased
plasma concentration of aspartate, glutamate and alanine
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concentration fell in post-weaning pigs. The prevention
of villi atrophy during the first week post-weaning also
has been reported by Wang and co-workers [46].
Liu and others [47] reported similar results than those
reported by Wu et al. [45]. They fed 1% L-glutamine or
1% L-glutamate to weaned pigs from 28-d to 42-d of
age. Jejunal atrophy was prevented during the first week
for the groups fed either L-GLN or L-glutamate when
compared to the control group. Again these results pro-
vide an experimental basis for the use of glutamine and
glutamate to improve piglet intestinal health and to sup-
port improved growth performance.
D-Xylose absorption test has been used as a tool for the
assessment of the effect of anticoccidials on the intestinal
absorptive capacity of broilers during experimental coc-
cidiosis [48] and malabsorption in poult enteritis and
mortality syndrome [25]. D-xylose, a poorly metabolized
pentose sugar, is well absorbed from the small intestine of
chickens and readily excreted in the urine [25]. Blood D-
xylose concentrations are expected to peak at 30–60 min
after intake in poultry [25,48] and 60 min in pigs [49,50].
Mannitol has been clinically applied in diagnostic and
therapeutic doses for 1) the determination of extracellular
fluid volume and glomerular filtration rate, 2) testing in-
testinal absorption and mucosal integrity, 3) as a diuretic
and 4) as a radical scavenger and osmotically active com-
ponent of infusions.
There are few studies using these two sugars as
markers of gastrointestinal in vivo permeability in pigs
in a commercial setting. In this study, the uptake of xylose
was greater than mannitol regardless of their molecular
weight (150 and 182 g/mol respectively) and the amount
administered (mannitol higher than xylose). Xylose can be
metabolized in the gut by bacteria, and then absorbed
whereas mannitol cannot. Therefore we would expect xy-
lose to be absorbed more rapidly than mannitol. Mannitol
is partially metabolized, the remainder being excreted in
the urine. Nasrallah and Iber [51] administered orally
doses of 20 to 100 g of 14C-mannitol to five humans with
cirrhosis of the liver and to five subjects who had normal
liver function. They found that at least one-sixth of orally
ingested mannitol is absorbed and about one-third is
metabolized.
The lack of significant differences in performance
among the treatments for the entire 6-wk period corre-
lates well with the lack of significant differences among
the treatments for the levels xylose and mannitol absorbed
and found in their blood. We were not surprised by the
high levels of intestinal absorptive capacity shown by the
sow reared pigs when compared to the other treatments.
These tests of small intestine permeability to low-
molecular-weight carbohydrates have a considerable
application in the study of small intestine diseases suchas celiac disease in humans [52], diagnosing food allergy
and assessing the effectiveness of anti-allergic agents
such as sodium cromoglycate [53].
In young animals, lactase activity prevails, however as it
gets older then maltase activity (as well amylases, lipases
proteases) increases. Low concentration of maltase in the
surface of epithelial cells may be an indication of villus at-
rophy due to disease or malnutrition [54]. We were unable
to find any significant differences among the treatments in
maltase activity.
Scanning electron microscopy (SEM) allows observa-
tion of the surface of the epithelium in three dimensions
and gives a fresh dimension in the investigation of gut
mucosa [55]. The visual assessment of the SEM graphs
showed that pigs which were not creep fed during the
suckling period had a rough villi surface with numerous
cells shedding (apoptosis) along the entire length of the
villi (Figure 2A). They also showed deep transversal fur-
rows in most (if not all) the epithelial cells (Figure 2A, B).
Those treatments creep fed either with a control diet or
supplemented with glutamine or Aminogut showed longer
villus than those treatments which were not creep fed (552
microns vs. 511 microns respectively) (Figure 2 D, E & F).
The CFGLN-GLN treatment showed elongated, well de-
fined and high villus (Figure 2G). Increased villus height
could increase total luminal villus absorption area and
could result in adequate digestive enzyme concentration
and/or increased transport of nutrient at the villus surface.
Gln has been shown to enhance epithelial repair in several
models of intestinal injury and to stimulate epithelial pro-
liferation and protein synthesis or reduce apoptosis in cell
culture [56,57]. Increased uptake of Gln in the crypts not
only could promote a compensatory increase in Na+ ab-
sorption but also would place this nutrient in the ideal lo-
cation to promote crypt cell production and restoration of
the villus architecture. The CGAG-AG treatment showed
deep and wide crypts. This could be explain by the fact
that glutamine is donating an amide group for the biosyn-
thesis of purines (adenine and guanine) and pyrimidines
(thymine and cytosine) which are the nucleotides bases to
support nucleic acid production (DNA) for rapidly divid-
ing cells in the crypts. In RNA, the complement of aden-
ine is uracil instead of thymine. The sow reared pigs
showed what may be the perfect villi structure: healthy,
well defined villus, no signs of apoptotic cells and suffi-
cient mucin production (Figure 2I). Mucins are a family of
high molecular weight, heavily glycosylated proteins
produced by epithelial tissues (specifically by the goblet
cells) in most metazoans. Two noticeable jejunal villi
structure characteristics in all treatments for 28 d pigs
were 1) transversal furrows that were present along the
entire length of the villi and 2) the shape of the villi were
not finger-like but rather wide and tongue-like in shape. It
was evident that the small intestinal mucosa undergoes
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the first 4 week of the pig’s life and these changes are
manifested in shape, size and density of the villi.
Conclusion
The supplementation of glutamine and glutamine plus
glutamate (AminoGut) in pre- and post-weaning diets
improved feed conversion in the first three week post-
weaning when compared to CFCD-CD treatment. These
findings are in the agreement with those reporting a re-
duction in villi atrophy when supplementing glutamine
at 1% in diets during the first week post-weaning. Sow
reared pigs showed the best intestinal absorptive capacity
and villi architecture. More research is needed at the field
level to justify the economical feasibility of adding either
glutamine or AminoGut in current commercial livestock
diets and the European model of weaning pigs at 28 d of
age. Consideration should also be given to potential
supplementation of the sow to enrich milk concentra-
tions [58].
The existing vast knowledge of the roles of functional
AA’s such as glutamine and others (arginine, glutamate,
proline, leucine, cysteine and tryptophan) provides the
scientific basis for nutritionists to revise current nutrient
requirements for livestock especially weaned pigs. These
findings indicate that strong consideration must be given
to GLN and glutamate as nutritionally essential amino
acids for post-weaning pigs diets.
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